These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30358070)

  • 1. Characterization of speech and language phenotype in children with NRXN1 deletions.
    Brignell A; St John M; Boys A; Bruce A; Dinale C; Pigdon L; Hildebrand MS; Amor DJ; Morgan AT
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):700-708. PubMed ID: 30358070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of NRXN1 deletions: clinical and molecular characterization.
    Dabell MP; Rosenfeld JA; Bader P; Escobar LF; El-Khechen D; Vallee SE; Dinulos MB; Curry C; Fisher J; Tervo R; Hannibal MC; Siefkas K; Wyatt PR; Hughes L; Smith R; Ellingwood S; Lacassie Y; Stroud T; Farrell SA; Sanchez-Lara PA; Randolph LM; Niyazov D; Stevens CA; Schoonveld C; Skidmore D; MacKay S; Miles JH; Moodley M; Huillet A; Neill NJ; Ellison JW; Ballif BC; Shaffer LG
    Am J Med Genet A; 2013 Apr; 161A(4):717-31. PubMed ID: 23495017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families.
    Al Shehhi M; Forman EB; Fitzgerald JE; McInerney V; Krawczyk J; Shen S; Betts DR; Ardle LM; Gorman KM; King MD; Green A; Gallagher L; Lynch SA
    Eur J Med Genet; 2019 Mar; 62(3):204-209. PubMed ID: 30031152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions.
    Schaaf CP; Boone PM; Sampath S; Williams C; Bader PI; Mueller JM; Shchelochkov OA; Brown CW; Crawford HP; Phalen JA; Tartaglia NR; Evans P; Campbell WM; Tsai AC; Parsley L; Grayson SW; Scheuerle A; Luzzi CD; Thomas SK; Eng PA; Kang SH; Patel A; Stankiewicz P; Cheung SW
    Eur J Hum Genet; 2012 Dec; 20(12):1240-7. PubMed ID: 22617343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature.
    Béna F; Bruno DL; Eriksson M; van Ravenswaaij-Arts C; Stark Z; Dijkhuizen T; Gerkes E; Gimelli S; Ganesamoorthy D; Thuresson AC; Labalme A; Till M; Bilan F; Pasquier L; Kitzis A; Dubourgm C; Rossi M; Bottani A; Gagnebin M; Sanlaville D; Gilbert-Dussardier B; Guipponi M; van Haeringen A; Kriek M; Ruivenkamp C; Antonarakis SE; Anderlid BM; Slater HR; Schoumans J
    Am J Med Genet B Neuropsychiatr Genet; 2013 Jun; 162B(4):388-403. PubMed ID: 23533028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion.
    Mei C; Fedorenko E; Amor DJ; Boys A; Hoeflin C; Carew P; Burgess T; Fisher SE; Morgan AT
    Eur J Hum Genet; 2018 May; 26(5):676-686. PubMed ID: 29445122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression.
    Lowther C; Speevak M; Armour CM; Goh ES; Graham GE; Li C; Zeesman S; Nowaczyk MJ; Schultz LA; Morra A; Nicolson R; Bikangaga P; Samdup D; Zaazou M; Boyd K; Jung JH; Siu V; Rajguru M; Goobie S; Tarnopolsky MA; Prasad C; Dick PT; Hussain AS; Walinga M; Reijenga RG; Gazzellone M; Lionel AC; Marshall CR; Scherer SW; Stavropoulos DJ; McCready E; Bassett AS
    Genet Med; 2017 Jan; 19(1):53-61. PubMed ID: 27195815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders.
    Ching MS; Shen Y; Tan WH; Jeste SS; Morrow EM; Chen X; Mukaddes NM; Yoo SY; Hanson E; Hundley R; Austin C; Becker RE; Berry GT; Driscoll K; Engle EC; Friedman S; Gusella JF; Hisama FM; Irons MB; Lafiosca T; LeClair E; Miller DT; Neessen M; Picker JD; Rappaport L; Rooney CM; Sarco DP; Stoler JM; Walsh CA; Wolff RR; Zhang T; Nasir RH; Wu BL;
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jun; 153B(4):937-47. PubMed ID: 20468056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic spectrum of NRXN1 mono- and bi-allelic deficiency: A systematic review.
    Castronovo P; Baccarin M; Ricciardello A; Picinelli C; Tomaiuolo P; Cucinotta F; Frittoli M; Lintas C; Sacco R; Persico AM
    Clin Genet; 2020 Jan; 97(1):125-137. PubMed ID: 30873608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare exonic NRXN3 deletion segregating with neurodevelopmental and neuropsychiatric conditions in a three-generation Chinese family.
    Yuan H; Wang Q; Liu Y; Yang W; He Y; Gusella JF; Song J; Shen Y
    Am J Med Genet B Neuropsychiatr Genet; 2018 Sep; 177(6):589-595. PubMed ID: 30076746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intragenic rearrangements in NRXN1 in three families with autism spectrum disorder, developmental delay, and speech delay.
    Wiśniowiecka-Kowalnik B; Nesteruk M; Peters SU; Xia Z; Cooper ML; Savage S; Amato RS; Bader P; Browning MF; Haun CL; Duda AW; Cheung SW; Stankiewicz P
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jul; 153B(5):983-93. PubMed ID: 20162629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.
    Gregor A; Albrecht B; Bader I; Bijlsma EK; Ekici AB; Engels H; Hackmann K; Horn D; Hoyer J; Klapecki J; Kohlhase J; Maystadt I; Nagl S; Prott E; Tinschert S; Ullmann R; Wohlleber E; Woods G; Reis A; Rauch A; Zweier C
    BMC Med Genet; 2011 Aug; 12():106. PubMed ID: 21827697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fraternal twins with autism, severe cognitive deficit, and epilepsy: diagnostic role of chromosomal microarray analysis.
    Imitola J; Walleigh D; Anderson CE; Jethva R; Carvalho KS; Legido A; Khurana DS
    Semin Pediatr Neurol; 2014 Jun; 21(2):167-71. PubMed ID: 25149956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous exonic and intragenic NRXN1 deletion presenting as either West syndrome or autism spectrum disorder in two siblings.
    Aksu Uzunhan T; Ayaz A
    Clin Neurol Neurosurg; 2022 Mar; 214():107141. PubMed ID: 35101781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further insight into the neurobehavioral pattern of children carrying the 2p16.3 heterozygous deletion involving NRXN1: Report of five new cases.
    Alfieri P; Scibelli F; Sinibaldi L; Valeri G; Caciolo C; Novello RL; Novelli A; Digilio MC; Tartaglia M; Vicari S
    Genes Brain Behav; 2020 Sep; 19(7):e12687. PubMed ID: 32658356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speech and language in DDX3X-neurodevelopmental disorder: A call for early augmentative and alternative communication intervention.
    Forbes EJ; Morison LD; Lelik F; Howell T; Debono S; Goel H; Burger P; Mandel JL; Geneviève D; Amor DJ; Morgan AT
    Am J Med Genet B Neuropsychiatr Genet; 2024 Sep; 195(6):e32971. PubMed ID: 38421120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NRXN1 deletions identified by array comparative genome hybridisation in a clinical case series - further understanding of the relevance of NRXN1 to neurodevelopmental disorders.
    Curran S; Ahn JW; Grayton H; Collier DA; Ogilvie CM
    J Mol Psychiatry; 2013; 1(1):4. PubMed ID: 25408897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical relevance of intragenic
    Cosemans N; Vandenhove L; Vogels A; Devriendt K; Van Esch H; Van Buggenhout G; Olivié H; de Ravel T; Ortibus E; Legius E; Aerssens P; Breckpot J; R Vermeesch J; Shen S; Fitzgerald J; Gallagher L; Peeters H
    J Med Genet; 2020 May; 57(5):347-355. PubMed ID: 31932357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A de novo microdeletion in NRXN1 in a Dutch patient with mild intellectual disability, microcephaly and gonadal dysgenesis.
    Agha Z; Iqbal Z; Kleefstra T; Zweier C; Pfundt R; Qamar R; VAN Bokhoven H; Willemsen MH
    Genet Res (Camb); 2015 Oct; 97():e19. PubMed ID: 26438105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early speech development in Koolen de Vries syndrome limited by oral praxis and hypotonia.
    Morgan AT; Haaften LV; van Hulst K; Edley C; Mei C; Tan TY; Amor D; Fisher SE; Koolen DA
    Eur J Hum Genet; 2018 Jan; 26(1):75-84. PubMed ID: 29225339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.